Calidi Biotherapeutics Inc (CLDI)
2.15
-0.14
(-6.11%)
USD |
NYAM |
Nov 21, 16:00
2.15
0.00 (0.00%)
After-Hours: 04:58
Calidi Biotherapeutics Debt to Equity Ratio
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| December 31, 2021 | -0.1582 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
-0.1582
Minimum
Dec 2021
-0.1582
Maximum
Dec 2021
-0.1582
Average
-0.1582
Median
Dec 2021
Debt to Equity Ratio Benchmarks
| Lumos Pharma Inc | 0.00 |
| Harrow Inc | 3.209 |
| Allurion Technologies Inc | -0.557 |
| NovaBay Pharmaceuticals Inc | 0.0476 |
| Palatin Technologies Inc | -- |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 6.657M |
| Total Liabilities (Quarterly) | 16.46M |
| Shareholders Equity (Quarterly) | -10.28M |